PharmaBoardroom

President of TWi Pharmaceuticals discusses soaring tax rates in the US market, why Taiwan is a more attractive market to currently build in and…

In the first part of this two-part interview, the Chairman of TTY Biopharm considers the success of his long-term strategy to streamline TTY's…

Dr. Patry holds a B.A.Sc. and M.A.Sc. in civil engineering from the University of Ottawa, and a Ph.D. from the University of California, Davis in…

Would you outline the commitment of the Ministry to foster a positive business environment for the Australian pharmaceutical industry to prosper?…

You established Menarini’s Irish affiliate in 1999. How have you seen the market evolve over these last 13 years? The major changes in the market…

The Aspen Group identified Latin America as a “large developing market where it can leverage its substantial intellectual property portfolio and…

If we look back at the conditions under which you founded Biocon in 1978, we see a young woman with a seed capital of only Rs. 10,000 in a garage in…

Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully…